MadisonDoctrineTardive DyskinesiaAdrenalineBlood PressureAutismSocialization FactorContactSite Map
Giddy Disinhibition Disorder
 
   

SOCIALIZATION FACTOR

THE “SOCIALIZATION FACTOR” OF THE BRAIN—ITS ACTIVATION AND ITS INHIBITION.”
PRESENTING A THEORY OF BRAIN FUNCTION WHICH OFFERS A POSSIBLE EXPLANATION FOR THE PHENOMENA SEEN IN AUTISM, SCHIZOPHRENIA, AND OTHER SOCIAL WITHDRAWAL DIFFICULTIES.

What we have discovered is that the medicine mecamylamine/ Inversine seems to act as a ‘talk pill‘ for many developmentally disabled individuals who formerly were limited in their conversation. The idea that a medication can help people talk at first seems peculiar – how can a pill affect talking? But consider that 100 years ago there would be a similar unbelief that a medicine could treat psychotic delusions and hallucinations.” Statement given to caregiver in summer 2003.

 Index to all parts of 'SOCIALIZATION FACTOR'
 Part 1 

MAJOR MENTAL ILLNESSES WITH INHIBITION OF SOCIALIZATION—BENEFIT OF ATYPICAL ANTIPSYCHOTICS.
1) “Negative symptoms” of schizophrenia and autistic social withdrawal.
1-a2) “Atypical antipsychotics” as “pro-socialization” medicines in schizophrenia.
cases {1 to 7 } principles [ 1 2 3 4 5 6 7 8 9 10 ]

   
 Part 2  IMPROVED TREATMENT OF SOCIALIZATION INHIBITION WITH THE GLYCINE/ SERINE RECEPTOR MEDICATIONS.
2-a2) The glutamate/ glycine nmda receptor mechanism.
2-b3) Recent studies using glycine receptor agonists in schizophrenia
2-b4) Nature of improvement using glycine-serine agonists
cases {8 to 11} principles [11 12 13 14 15 16 17 18 ]
   
 Part 3  BEHAVIORAL AND NON-TRADITIONAL TREATMENTS FOR THE SOCIAL WITHDRAWAL OF AUTISM.
3-a) Intense behavioral programs
3-b) Treatment stories of individuals.
3-c) The “alternative treatments” for autism
cases {12 to 20} principles [ 19 20 21 22 23 24 25 26 27 28 29]
   
 Part 4  “SOCIAL INHIBITION ” AS A UNIVERSAL PROPERTY OF THE BRAIN – THE LESSONS OF THE MECAMYLAMINE/ INVERSINE EXPERIENCE
4- b) Unexpected prosocialization effects.
4-C1) Descriptions of effects of mecamylamine/ Inversine treatment given by caregivers.
4-e) What is different about this use of mecamylamine/ inversine?
4-f) The socialization factor in the very young and mecamylamine/ Inversine.
4-g) Summary - Atypical results using mecamylamine /inversine in developmentally disabled.
cases {21 to 27} principles [ 30 31]
   
 Part 5  SEEKING AN UNDERSTANDING OF THE SOCIALIZATION FACTOR AND ITS RELATIONSHIP TO CLINICAL PSYCHIATRY.
5-B) Clues to the nature of the socialization factor and its treatment.
5-B1) Clue 1- The “two primitive selves” concept of Margaret Mahler
5-B1.2) Clue 2- Dissociation – the possible mechanism by which the blocking of the socialization factor occurs.
5-b1.3) Clue 3- The possibility of dissociation being a function of the mnda (glutamine/glycine) receptor mechanism.
5-B1.3a\2) Persistence of response with glycine agonists.
5-B1.3a\3) Persistence of the effects of the hallucinogenic drugs.
5-B1.3b) Other ”coincidental” understandings concerning the NMDA receptor mechanism and its possible effect on dissociative blocking.
5-B1.3b\1a Successful treatment of catatonia with memantine/ Namenda.
Cases {28} Principles [32 33 34]
   
 Part 6  DEALING WITH THE GOOD AND THE BAD OF “PROSOCIALIZATION THERAPY.
6-A) The problem of agitated behavior.
6-B) Comparisons of “socialization side effects” with the major psychiatric breaks.
6-B 1a) The schizophrenic break- a breakthrough of the autistic phase dissociation.
6-B2.a) The manic break – the release of the grandiose “symbiotic” socialization drive.
6-B3) All prosocialization medications can cause disinhibited behavior.
Principles [35 36 37]
   
 Part 7  DESCRIPTION OF PROSOCIALIZATION MEDICATIONS.
7-A2) Non-activating atypicals: olanzapine/ Zyprexa, quetiapine /Seroquel, clozapine/ Clozaril.
7-A3) The activating atypical antipsychotics
7-C) Non-antipsychotic Prosocialization Meds
7-C1.a) The glycine agonists.
7-C1.b) NMDA acting medications. memantine/ Namenda, acamprosate/ Campral. lamotrigine/ Lamictal, dextromethorphan.
7-C1.c) mecamylamine/ Inversine (non-competitive nicotinergic antagonist.)
7-D) Other medications with activating and possible prosocialization properties
7-D1) Alcohol and benzodiazepine anti-anxiety meds.
7-D2) Antidepressants
7-D3) Stimulants
7-D4) Chemicals which may relate to prosocialization effects
7-D4.a-b) Oxytocin., PEA (phenylethylamine)
7- D5) Elimination of the “Antisocialization medicine” phenytoin/ Dilantin.
7-D5.a Elimination or lowering of typical antipsychotic or high dose atypical
   
 Part 8  DESCRIPTION OF STABILIZATION MEDICATIONS
8-A1) Typical antipsychotics
8-A2) Atypical antipsychotics
8-B) Mood stabilizers for treating over-activating effects of prosocializing medicines.–
8-C) Summary of prosocialization treatment.
   
 Unit 9  THE USE OF THE SOCIALIZATION FACTOR IN APPROACHING AUTISM
9-A Four general opinions about autism counter to the madisondoctrine’s experience.
9-A1 1) Autism is a genetic condition.
9-A2 2) Medication helps the behavior of autistic individuals but does not change the basic disorder of Autism
9-A3 3) Young children with Autism should be placed in behavioral programs early, but medicines should be withheld as a last resort.
9-A4 4) Since there are no medicines which have proven benefit, medication trials should be done one medicine at a time.

9- B1 Problems applying the concept of the socialization factor to autism.
9- B1.a) Lack of any universally acceptable understanding about the autism phenomenon
9-C WHAT MIGHT BE DONE BY THOSE WHO WANT TO USE THE CONCEPTS OF PROSOCIALIZATION IN TREATMENT.
9-C2 Non-physicians


  INTRODUCTION:

This paper presents the possibility that there is a process in every brain which either gives or denies “permission” for the individual to participate in or to block out the socializing functions of the brain – especially speech. The phenomenon of blocking socialization is seen as a consequence of normal societal structure but capable of causing symptoms of mental illness in some situations.

 SUMMARY: 

This paper seeks to present the concept of the presence of socialization factor as part of the functioning brain. This concept has two parts. Part 1 –the “socialization factor” and its inhibition, Part 2 – the “primitive psychotic drives” which are the extremes of brain functions that influenced the growth of the individual’s socialization experience.

The “socialization factor” has qualities not typical of standard brain functions. It is unique in that it can be dormant for an extended time then suddenly function; its treatment is unique in that a number of widely divergent neuro-chemical systems seem to affect it; and treatment is also unique in that a time-limited treatment may cause a prolonged benefit. It may be that the socialization factor is a dissociative reaction; it may be intimately connected with the MNDA glutamate system; or both statements may be true. “Prosocialization medications”, which include atypical antipsychotics, various glycine agonists, glutamate antagonists, and the nicotinic antagonist mecamylamine, can stimulate the emergence of increased socialization but can also produce severe behavioral disruptions in some individuals. These disruptions have demonstrated qualities which suggested part B of this theory – the presence of “primitive psychotic drives.”

“Primitive psychotic drives.” apparently represent the expression of the extremes of psychotic-like socialization drives which are dissociatively suppressed during normal brain function, but seem to be the force behind the two major psychiatric breaks—the autistic, socially-isolating psychosis of the schizophrenic break and the socially intrusive disinhibited dysfunction of the manic break. These two primitive drives parallel the first two infantile developmental phases conceived by the child psychiatrist, Margaret Mahler – the autistic phase and the symbiotic phase.

Determining whether there is a true relationship between the clinical observations presented and such foundationally novel theories will require extensive controlled clinical study. Indeed, the observations and theories on which the concept of the socialization factor is formulated are incomplete, hard to substantiate, and quite subject to skepticism. However, the material presented does contain observations by myself and others that are not easily explained using other models of psychopathology. Thus this paper is set forth with the hope that others will seek to develop experience dealing with the area of behavior which has been termed the “socialization factor” and that the concept of “prosocialization treatment” will be expanded to reach the large number of patients that it promises to help.

 
MadisonDoctrineTardive DyskinesiaAdrenalineBlood PressureAutismSocialization Factor | ContactSite Map
Giddy Disinhibition Disorder